Clinical Trial Update: Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) [Phase 4]

View source ↗

Summary

Phase 4 trial PENFOSIDINE is evaluating pentoxifylline in patients with diabetic nephropathy and chronic kidney disease stage 3-4; the current status is not dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Maria Eugenia Galván Plata | Conditions: Chronic Kidney Disease stage3 and 4, Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN